| RPRX Stock | | | USD 31.59 0.36 1.13% |
Royalty Pharma financial indicator trend analysis is much more than just breaking down Royalty Pharma Plc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Royalty Pharma Plc is a good investment. Please check the relationship between Royalty Pharma Net Income and its Capital Expenditures accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Royalty Pharma Plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
Net Income vs Capital Expenditures
Net Income vs Capital Expenditures Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Royalty Pharma Plc Net Income account and
Capital Expenditures. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Royalty Pharma's Net Income and Capital Expenditures is 0.58. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Capital Expenditures in the same time period over historical financial statements of Royalty Pharma Plc, assuming nothing else is changed. The correlation between historical values of Royalty Pharma's Net Income and Capital Expenditures is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of Royalty Pharma Plc are associated (or correlated) with its Capital Expenditures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Expenditures has no effect on the direction of Net Income i.e., Royalty Pharma's Net Income and Capital Expenditures go up and down completely randomly.
Correlation Coefficient | 0.58 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Royalty Pharma Plc financial statement analysis. It represents the amount of money remaining after all of Royalty Pharma Plc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Capital Expenditures
Capital Expenditures are funds used by Royalty Pharma Plc to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Royalty Pharma operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most indicators from Royalty Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Royalty Pharma Plc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Royalty Pharma Plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
At this time, Royalty Pharma's
Selling General Administrative is fairly stable compared to the past year.
Enterprise Value Over EBITDA is likely to rise to 21.21 in 2025, whereas
Sales General And Administrative To Revenue is likely to drop 0.06 in 2025.
Royalty Pharma fundamental ratios Correlations
Click cells to compare fundamentals
Royalty Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Royalty Pharma fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Royalty Stock Analysis
When running Royalty Pharma's price analysis, check to
measure Royalty Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royalty Pharma is operating at the current time. Most of Royalty Pharma's value examination focuses on studying past and present price action to
predict the probability of Royalty Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royalty Pharma's price. Additionally, you may evaluate how the addition of Royalty Pharma to your portfolios can decrease your overall portfolio volatility.